Description

▪ Introduction

Tamoxen 25 contains pharmaceutical-grade Tamoxifen Citrate, a selective estrogen receptor modulator (SERM) extensively used in laboratory and analytical research to study estrogen receptor interactions and related cellular mechanisms. Manufactured by Novotex Pharma, this product is supplied as blister-packed tablets for precise and controlled dosing in research environments.

▪ Product Details

• Active Ingredient: Tamoxifen Citrate

• Dosage Strength: 25 mg per tablet

• Form: Oral tablets

• Brand: Novotex Pharma

• Package Size: 60 tablets (boxed, blister-packed)

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Tamoxifen Citrate is well absorbed orally and undergoes extensive hepatic metabolism via cytochrome P450 enzymes. Its active metabolites exhibit a half-life ranging from 5 to 7 days in simulated systems. The compound modulates estrogen receptor activity, making it valuable for in-vitro and in-vivo modeling of estrogen-related biochemical pathways.

▪ Usage Recommendations

Typical laboratory protocols simulate a dosage of 10–25 mg daily, depending on experimental design. Tablets should be stored in original blister packaging to ensure stability and handled according to standard laboratory safety procedures.

▪ Disclaimer

This product is intended strictly for laboratory research and analytical use. Not for human consumption or medical treatment. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health conditions. Must be handled according to local regulations and laboratory safety standards.